Lichen Simplex Chronicus

Lichen simplex chronicus (LSC) is a chronic inflammatory dermatosis that can affect different districts of the skin. It is characterized by intense itching, thickening of the skin and spots with papules. The intense itching causes scratching and injury of the skin.

In the specific context of the genital pathology, it appears with scaly patches of greyish color, often scaly and thickened skin. Scratching can lead to the formation of injury and micro scabs. In lichen simplex chronicus to the genitals, itching often adds also burning sensation.

Lichen simplex chronicus can occur as a result of other dermatosis, or stress and emotional tension.

In the 2016 European Guideline for the management of vulval conditions Dermasilk Intimo Briefs have been mentioned as an alternative regimen in the management of Lichen Simplex Chronicus "...Silk fabric underwear may reduce the need for topical corticosteroids..."


The restoration of the skin’s integrity occurs thanks to the reduction/elimination of anything that can irritate the skin; for this reason, the choice of underwear is very important in lichen simplex chronicus.
It should be avoided synthetic underwear because is very irritating and not very breathable. Among the natural fabrics, the most known and used in case of skin diseases is cotton. Recent studies, however, show how the short fibers of cotton can be irritating: they absorb and give moisture with a typical spiral movement.

DermaSilk® briefs, made ​​of pure silk fibroin microbiologically protected, are designed to promote balance and well-being of the genital area. Clinical studies have shown that in the short term reduce irritation, itching, burning and pain and that they are effective in the treatment/prevention of bacterial and fungal infections and dermatitis.

DermaSilk Intimo briefs demonstrated its efficacy in Lichen Simplex Chronicus:
“Effectiveness of silk fabric underwear as an adjuvant tool in the management of vulvar lichen simplex chronicus: results of a double-blind randomized controlled trial.” Menopause 2015